Jul 03, 2020

Pandemic a catalyst for boosting commercial outcomes, says Starpharma CEO

Pandemic a catalyst for boosting commercial outcomes, says Starpharma CEO

The Age recently interviewed Starpharma CEO Dr Jackie Fairley to discuss how the COVID19 pandemic could be the catalyst for the pharmaceutical industry to improve the way they convert important research into commercial products. The article highlighted Starpharma’s recent activities in response to the pandemic, including the development of a product using its existing anti-viral dendrimer SPL7013.

To read the full article, click here.

 This contains certain forward-looking statements.